Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in moderate to severe asthma
NCT04353310Phase 2Withdrawn
- Sponsor
- Loma Linda University
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of curcumin in asthma, sponsored by Loma Linda University. Planned start Sep 2021; status: withdrawn.
02
Drugs
curcumin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04353310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353310.